Aytu BioPharma, Inc.: Aytu BioPharma Announces Issuance of Its First Patent for AR101/Enzastaurin
First Issued U.S. Patent Covers Methods of Treating a Broad Range of Inherited Aortic Aneurism and Related Conditions Including Vascular Ehlers-Danlos SyndromeMultiple Patent Families Filed in Key Global
Source: finanznachrichten.de